Interestingly, we showed here that C11 treatment was much more effective at recovering neuronal survival than treatment with NP12 in both in vitro and in vivo experimental models of CDD, suggesting that the C11 pro-survival effect is conveyed to HDAC6 inhibition. Here, HDAC6 is linked to craniodiaphyseal dysplasia.